Dulaglutide vs Ipilimumab

Dulaglutide vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Dulaglutide and Ipilimumab.

Mechanism of Action

Dulaglutide: GLP-1 receptor agonist fused to Fc fragment; enhances glucose-dependent insulin secretion.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Dulaglutide — 5 days; Ipilimumab — 14.7 days.

Chemical Properties

Type: Dulaglutide — Protein; Ipilimumab — Antibody.